The DOI matches its Crossref record; 1,227 of the 1,227 references it cites were found in a registry or an index.
Dopamine, Immunity, and Disease
Open accessAbstract
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function, regulating many processes including reward, movement, and cognition. Dopamine also regulates critical functions in peripheral organs, such as blood pressure, renal activity, and intestinal motility. Beyond these functions, a growing body of evidence indicates that dopamine is an important immunoregulatory factor. Most types of immune cells express dopamine receptors and other dopaminergic proteins, and many immune cells take up, produce, store, and/or release dopamine, suggesting that dopaminergic immunomodulation is important for immune function. Targeting these pathways could be a promising avenue for the treatment of inflammation and disease, but despite increasing research in this area, data on the specific effects of dopamine on many immune cells and disease processes remain inconsistent and poorly understood. Therefore, this review integrates the current knowledge of the role of dopamine in immune cell function and inflammatory signaling across systems. We also discuss the current understanding of dopaminergic regulation of immune signaling in the CNS and peripheral tissues, highlighting the role of dopaminergic immunomodulation in diseases such as Parkinson's disease, several neuropsychiatric conditions, neurologic human immunodeficiency virus, inflammatory bowel disease, rheumatoid arthritis, and others. Careful consideration is given to the influence of experimental design on results, and we note a number of areas in need of further research. Overall, this review integrates our knowledge of dopaminergic immunology at the cellular, tissue, and disease level and prompts the development of therapeutics and strategies targeted toward ameliorating disease through dopaminergic regulation of immunity. SIGNIFICANCE STATEMENT: Canonically, dopamine is recognized as a neurotransmitter involved in the regulation of movement, cognition, and reward. However, dopamine also acts as an immune modulator in the central nervous system and periphery. This review comprehensively assesses the current knowledge of dopaminergic immunomodulation and the role of dopamine in disease pathogenesis at the cellular and tissue level. This will provide broad access to this information across fields, identify areas in need of further investigation, and drive the development of dopaminergic therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 601–800 of 1,227
Dopamine: an immune transmitter
Broome, S. T., Louangaphay, K., Keay, K. A., Leggio, G. M., Musumeci, G., & Castorina, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.284976 · Cited by 115
Guo, Y., Zhu, X., Zeng, M., Qi, L., Tang, X., Wang, D., Zhang, M., Xie, Y., Li, H., Yang, X., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01443-2 · Cited by 115
Impact of antidepressants on cytokine production of depressed patients in Vitro
Munzer, A., Sack, U., Mergl, R., Schönherr, J., Petersein, C., Bartsch, S., Kirkby, K., Bauer, K., & Himmerich, H. (2013) · Toxins · doi:10.3390/toxins5112227 · Cited by 114
Rinne, J. O., Laihinen, A., Ruottinen, H., Ruotsalainen, U., Någren, K., Lehikoinen, P., Oikonen, V., & Rinne, U. K. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00137-q · Cited by 114
Electrophysiologic and proarrhythmic effects of intravenous inotropic agents
Tisdale, J. E., Patel, R. V., Webb, C. R., Borzak, S. L., & Zarowitz, B. J. M. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80005-2 · Cited by 114
Nakano, K., Yamaoka, K., Hanami, K., Saito, K., Sasaguri, Y., Yanagihara, N., Tanaka, S., Katsuki, I., Matsushita, S., & Tanaka, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002475 · Cited by 114
Depression in Autoimmune Diseases
Pryce, C. R., & Fontana, A. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_7 · Cited by 114
Qiu, J., Yan, Z., Tao, K. X., Li, Y., Li, Y., Li, J., Dong, Y., Feng, D., & Chen, D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0739-8 · Cited by 114
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures
Dominguez‐Meijide, A., Rodriguez-Perez, A. I., Díaz-Ruiz, C., Guerra, M. J., & Labandeira-García, J. L. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.013 · Cited by 114
White matter damage, neuroinflammation, and neuronal integrity in HAND
for the CHARTER Group, Alakkas, A., Ellis, R. J., Watson, C. W., Umlauf, A., Heaton, R. K., Letendre, S. L., Collier, A. C., Marra, C. M., Clifford, D. B., et al. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-018-0682-9 · Cited by 114
l-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells
Stansley, B. J., & Yamamoto, B. K. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.010 · Cited by 112
Boileau, I., Guttman, M., Rusjan, P., Adams, J. R., Houle, S., Tong, J., Hornykiewicz, O., Furukawa, Y., Wilson, A. A., Kapur, S., et al. (2009) · Brain · doi:10.1093/brain/awn337 · Cited by 112
Cussac, D., Newman‐Tancredi, A., Pasteau, V., & Millan, M. J. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.1025 · Cited by 112
Dopamine Receptor Signaling and Current and Future Antipsychotic Drugs
Boyd, K. N., & Mailman, R. B. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_3 · Cited by 111
Saha, B., Mondal, A. C., Basu, S., & Dasgupta, P. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00068-6 · Cited by 111
Dopamine receptors on human T- and B-lymphocytes
Santambrogio, L., Lipartiti, M., Bruni, A., & Toso, R. D. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90170-4 · Cited by 111
Dopamine Receptors in Human Adipocytes: Expression and Functions
Borcherding, D. C., Hugo, E. R., Idelman, G., Silva, A. D., Richtand, N. W., Loftus, J., & Ben‐Jonathan, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025537 · Cited by 111
Sources and Physiological Significance of Plasma Dopamine Sulfate
Goldstein, D. S., Swoboda, K. J., Miles, J. M., Coppack, S. W., Aneman, A., Holmes, C., Lamensdorf, I., & Eisenhofer, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5864 · Cited by 111
Dopamine Activates Noradrenergic Receptors in the Preoptic Area
Cornil, C. A., Balthazart, J., Motté, P., Massotte, L., & Seutin, V. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09320.2002 · Cited by 111
Wang, T., Nowrangi, D., Yu, L., Lu, T., Tang, J., Han, B., Ding, Y., Fu, F., & Zhang, J. H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1039-7 · Cited by 111
Dopamine Selectively Induces Migration and Homing of Naive CD8+ T Cells via Dopamine Receptor D3
Watanabe, Y., Nakayama, T., Nagakubo, D., Hieshima, K., Jin, Z., Katou, F., Hashimoto, K., & Yoshie, O. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.848 · Cited by 110
So, C. H., Verma, V., Alijaniaram, M., Cheng, R., Rashid, A. J., O’Dowd, B. F., & George, S. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.051805 · Cited by 110
Kuštrimović, N. Z., Rasini, E., Legnaro, M., Bombelli, R., Aleksić, I., Blandini, F., Comi, C., Mauri, M. F., Minafra, B., Riboldazzi, G., et al. (2016) · Scientific Reports · doi:10.1038/srep33738 · Cited by 110
Ilani, T., Strous, R. D., & Fuchs, S. (2004) · The FASEB Journal · doi:10.1096/fj.04-1652fje · Cited by 109
Meng, S. Z., Ozawa, Y., Itoh, M., & Takashima, S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01933-2 · Cited by 109
Luo, Y., Kokkonen, G. C., Wang, X., Neve, K. A., & Roth, G. S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71030980.x · Cited by 108
Eosinophils are key regulators of perivascular adipose tissue and vascular functionality
Withers, S., Forman, R. A., Meza‐Perez, S., Sorobetea, D., Sitnik, K., Hopwood, T. W., Lawrence, C. B., Agace, W. W., Else, K. J., Heagerty, A. M., et al. (2017) · Scientific Reports · doi:10.1038/srep44571 · Cited by 108
Poly, T. N., Islam, M. M., Yang, H., & Li, Y.-C. J. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2561-y · Cited by 108
Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD)
Marco, P., Bertella, S., Gatti, E., Peeters, G. G. A. M., Carnovale, C., Zambrano, S., & Nobile, M. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1820481 · Cited by 107
Pathmanandavel, K., Starling, J., Merheb, V., Ramanathan, S., Sinmaz, N., Dale, R. C., & Brilot, F. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.014 · Cited by 106
Dopamine D1 Receptor-induced Signaling through TrkB Receptors in Striatal Neurons
Iwakura, Y., Nawa, H., Sora, I., & Chao, M. V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801553200 · Cited by 106
Coughlin, J. M., Wang, Y.-C., Ma, S., Yue, C., Kim, P. K., Adams, A. V., Roosa, H. V., Gage, K., Stathis, M., Rais, R., et al. (2014) · Journal of Neurovirology · doi:10.1007/s13365-014-0239-5 · Cited by 106
Štrac, D. Š., Pivac, N., Smolders, I. J., Fogel, W. A., Deurwaerdère, P. D., & Giovanni, G. D. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00492 · Cited by 106
On the Presence of 3-Hydroxytyramine in Brain
Carlsson, A., Lindqvist, M., Magnusson, T., & Waldeck, B. (1958) · Science · doi:10.1126/science.127.3296.471.a · Cited by 106
Bergquist, J., Josefsson, E., Tarkowski, A., et al. (1997) · Electrophoresis · doi:10.1002/elps.1150181009 · Cited by 105
Hoeppner, L. H., Wang, Y., Sharma, A. K., Javeed, N., Keulen, V. P. V., Wang, E., Yang, P., Roden, A. C., Peikert, T., Molina, J. R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.08.008 · Cited by 105
Neuronal damage of the substantia nigra in HIV-1 infected brains
Itoh, K., Mehraein, P., & Weis, S. (2000) · Acta Neuropathologica · doi:10.1007/s004010051139 · Cited by 105
Holmes, S. E., Hinz, R., Drake, R., Gregory, C. J., Conen, S., Matthews, J. C., Anton‐Rodriguez, J., Gerhard, A., & Talbot, P. S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.180 · Cited by 105
Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson’s disease
Finberg, J. P. M. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1952-7 · Cited by 105
Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD)
Darwish, A. H., Elgohary, T. M., & Nosair, N. A. E.-A. (2018) · Journal of Child Neurology · doi:10.1177/0883073818809831 · Cited by 105
Impact of antipsychotics on cytokine production in-vitro
Himmerich, H., Schönherr, J., Fulda, S., Sheldrick, A. J., Bauer, K., & Sack, U. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.04.009 · Cited by 104
Bone mass in schizophrenia and normal populations across different decades of life
Renn, J.-H., Yang, N., Chueh, C., Lin, C., Lan, T., & Chou, P. (2009) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-10-1 · Cited by 103
Yan, Q., & Yan, S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00913-x · Cited by 103
Xin, W., Schuebel, K. E., Jair, K.-W., Cimbro, R., Biase, L. M. D., Goldman, D. A., & Bonci, A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0151-4 · Cited by 103
Bankier, B., Barajas, J., Martinez-Rumayor, A., & Januzzi, J. L. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn326 · Cited by 102
Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity
Ortega, M., Brier, M. R., & Ances, B. M. (2015) · AIDS · doi:10.1097/qad.0000000000000611 · Cited by 102
The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
Vidal, P. M., & Pacheco, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00394 · Cited by 102
Dopaminergic effects on in vitro osteogenesis
Lee, D. J., Tseng, H. C., Wong, S. W., Wang, Z., Deng, M., & Ko, C.-C. (2015) · Bone Research · doi:10.1038/boneres.2015.20 · Cited by 101
D5 Dopamine Receptors are Required for Dopaminergic Activation of Phospholipase C
Sahu, A., Tyeryar, K. R., Vongtau, H. O., Sibley, D. R., & Undieh, A. S. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.053017 · Cited by 101
STERNBERG, E. M., Wedner, H. J., Leung, M. K. G., & Parker, C. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.12.4360 · Cited by 100
Neuron‐specific age‐related decreases in dopamine receptor subtype mRNAs
Hemby, S. E., Trojanowski, J. Q., & Ginsberg, S. D. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10525 · Cited by 100
Neuronal Source of Plasma Dopamine
Goldstein, D. S., & Holmes, C. S. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.107193 · Cited by 100
Catecholamines in a macrophage cell line
Brown, S. W., Meyers, R. T., Brennan, K. M., Rumble, J. M., Narasimhachari, N., Perozzi, E. F., Ryan, J. J., Stewart, J. K., & Fischer‐Stenger, K. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00435-6 · Cited by 100
FAWCETT, J. A., Rush, A. J., Vukelich, J., Diaz, S. H., Dunklee, L., Romo, P. E., Yarns, B. C., & Escalona, R. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060788 · Cited by 100
HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment
Carroll, A. S., & Brew, B. J. (2017) · F1000Research · doi:10.12688/f1000research.10651.1 · Cited by 100
Hasbi, A., Nguyen, T., Rahal, H., Manduca, J. D., Miksys, S. L., Tyndale, R. F., Madras, B. K., Perreault, M. L., & George, S. R. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00285-9 · Cited by 100
Dopamine, the Kidney, and Hypertension
Harris, R. C., & Zhang, M. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0253-z · Cited by 99
Alghamri, M. S., McClellan, B. L., Hartlage, C. S., Haase, S., Faisal, S. M., Thalla, R., Dabaja, A. A., Banerjee, K., Carney, S. V., Mujeeb, A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680021 · Cited by 99
Nair, V. D., & Sealfon, S. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303364200 · Cited by 98
Marcondes, M. C. G., Flynn, C. T., Watry, D. D., Zandonatti, M. A., & Fox, H. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090953 · Cited by 98
Yang, Z., Asico, L. D., Yu, P., Wang, Z., Jones, J. E., Escano, C. S., Wang, X., Quinn, M. T., Sibley, D. R., Romero, G. G., et al. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00434.2005 · Cited by 98
Côtel, M.-C., Lenartowicz, E. M., Natesan, S., Modo, M., Cooper, J. D., Williams, S., Kapur, S., & Vernon, A. C. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.004 · Cited by 98
Maestroni, G. J. M., Cosentino, M., Marino, F., Togni, M., Conti, A. M. F., Lecchini, S., & Frigo, G. M. (1998) · PubMed · Cited by 98
Chemotaxis of Escherichia coli to major hormones and polyamines present in human gut
Lopes, J., & Sourjik, V. (2018) · The ISME Journal · doi:10.1038/s41396-018-0227-5 · Cited by 98
De Novo Expression of Dopamine D2 Receptors on Microglia after Stroke
Huck, J. H. J., Freyer, D., Böttcher, C., Mladinov, M., Muselmann, C., Thielke, M., Gladow, N., Bloomquist, D., Mergenthaler, P., & Priller, J. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.128 · Cited by 97
Pellicano, C., Pontieri, F. E., Fanciulli, A., & Buttarelli, F. R. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596612 · Cited by 97
Carlsson and the discovery of dopamine
Benes, F. M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01607-2 · Cited by 97
Wu, Y., Hu, Y., Wang, B., Li, S., Ma, C., Liu, X., Moynagh, P. N., Zhou, J., & Yang, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.022 · Cited by 97
Ghosh, M. C., Mondal, A. C., Basu, S., Banerjee, S., Majumder, J., Bhattacharya, D., & Dasgupta, P. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00100-0 · Cited by 96
Gelman, B. B., Lisinicchia, J. G., Chen, T., Johnson, K. M., Jennings, K., Freeman, D. H., & Soukup, V. M. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9345-4 · Cited by 96
Wegner, F., Wilke, F., Raab, P., Tayeb, S. B., Boeck, A.-L., Haense, C., Trebst, C., Voß, E. V., Schrader, C., Logemann, F., et al. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-136 · Cited by 96
Ipser, J., Brown, G. G., Bischoff‐Grethe, A., Connolly, C. G., Ellis, R. J., Heaton, R. K., & Grant, I. (2015) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617715000156 · Cited by 96
Yang, H., Xu, Y., Zhu, M., Gu, Y., Zhang, W., Shao, H., Wang, Y., Ping, Z., Hu, X., Wang, L., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.046 · Cited by 96
Effects of Neurological Disorders on Bone Health
Kelly, R. R., Sidles, S. J., & LaRue, A. C. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.612366 · Cited by 96
Aslanoglou, D., Bertera, S., Sánchez-Soto, M., Benjamin Free, R., Lee, J., Zong, W., Xue, X., Shrestha, S., Brissova, M., Logan, R. W., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01171-z · Cited by 96
Maatouk, L., Compagnion, A.-C., Sauvage, M.-A. C.-D., Bemelmans, A.-P., Leclere-Turbant, S., Cirotteau, V., Tohme, M., Beke, A., Trichet, M., Bazin, V., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04569-y · Cited by 95
Role of Proximal Tubules in the Pathogenesis of Kidney Disease
Nakhoul, N. L., & Batuman, V. (2011) · Contributions to nephrology · doi:10.1159/000313944 · Cited by 95
Torres, K., Antonelli, L. R. D. V., Souza, A. L. S., Teixeira, M. M., Dutra, W. O., & Gollob, K. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.006 · Cited by 95
Zeng, C., & José, P. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157727 · Cited by 95
Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients
Kwak, Y. T., Koo, M., Choi, C.-H., & In, S. (2001) · BMC Medical Genetics · doi:10.1186/1471-2350-2-3 · Cited by 95
Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure
Yamaguchi, T., Sumida, T. S., Nomura, S., Satoh, M., Higo, T., Ito, M., Ko, T., Fujita, K., Sweet, M., Sanbe, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18128-x · Cited by 95
Chen, J., Marmur, R., Pulles, A., Paredes, W. M., & Gardner, E. L. (1993) · Brain Research · doi:10.1016/0006-8993(93)90298-2 · Cited by 94
Astroglial dopamine transport is mediated by norepinephrine transporter
Takeda, H., Inazu, M., & Matsumiya, T. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0640-0 · Cited by 94
Wilson, H., Dervenoulas, G., Pagano, G., Tyacke, R. J., Polychronis, S., Myers, J., Gunn, R. N., Rabiner, E. A., Nutt, D., & Politis, M. (2019) · Brain · doi:10.1093/brain/awz260 · Cited by 94
Tyrosinase: a developmentally specific major determinant of peripheral dopamine
Eisenhofer, G., Tian, H., Holmes, C. S., Matsunaga, J., Roffler-Tarlov, S. K., & Hearing, V. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0736com · Cited by 93
Role of dopamine in schizophrenia and Parkinson's disease
Birtwistle, J., & Baldwin, D. S. (1998) · British Journal of Nursing · doi:10.12968/bjon.1998.7.14.5636 · Cited by 93
González, S., Rangel‐Barajas, C., Peper, M., Lorenzo, R., Moreno, E., Ciruela, F., Borycz, J. A., Ortiz, J., Lluís, C., Franco, R., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.93 · Cited by 93
Astrocytes Resist HIV-1 Fusion but Engulf Infected Macrophage Material
Russell, R. A., Chojnacki, J., Jones, D. M., Johnson, E., Do, T., Eggeling, C., Padilla‐Parra, S., & Sattentau, Q. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.027 · Cited by 93
The evolution of HIV-1 entry phenotypes as a guide to changing target cells
Joseph, S., & Swanstrom, R. I. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2ri0517-200r · Cited by 93
Localization of Targets for Anti-Ulcer Drugs in Cells of the Immune System
Mezey, É., & Palkovits, M. (1992) · Science · doi:10.1126/science.1333642 · Cited by 92
The role of macrophages in anti-inflammatory activity of antidepressant drugs
Nazimek, K., Strobel, S. D., Bryniarski, P., Kozlowski, M., Filipczak-Bryniarska, I., & Bryniarski, K. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.07.001 · Cited by 92
Ren, L., Yi, J., Yang, J., Li, P., Cheng, X., & Mao, P. (2018) · Medicine · doi:10.1097/md.0000000000012172 · Cited by 92
Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor
Peterson, S. M., Pack, T. F., Wilkins, A. D., Urs, N. M., Urban, D. J., Bass, C. E., Lichtarge, O., & Caron, M. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502742112 · Cited by 91
Disorders of Tetrahydrobiopterin Metabolism and their Treatment
Shintaku, H. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605145 · Cited by 91
Bijlsma, E. Y., Chan, J. S. W., Olivier, B., Veening, J. G., Millan, M. J., Waldinger, M. D., & Oosting, R. S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.004 · Cited by 91
Methamphetamine Enhances HIV-1 Infectivity in Monocyte Derived Dendritic Cells
Nair, M., Saiyed, Z. M., Nair, N. M., Gandhi, N. H., Rodríguez, J. W., Boukli, N. M., Provencio‐Vasquez, E., Malow, R. M., & Míguez‐Burbano, M. J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9128-0 · Cited by 91
D1-D2 Dopamine Receptor Synergy Promotes Calcium Signaling via Multiple Mechanisms
Chun, L. S., Free, R. B., Doyle, T. B., Huang, X., Rankin, M. L., & Sibley, D. R. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085175 · Cited by 91
Pellegrini, C., Fornai, M., Colucci, R., Tirotta, E., Blandini, F., Levandis, G., Cerri, S., Segnani, C., Ippolito, C., Bernardini, N., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0608-5 · Cited by 91
Wang, W., Cohen, J. A., Wallrapp, A., Trieu, K. G., Barrios, J., Shao, F., Krishnamoorthy, N., Kuchroo, V. K., Jones, M. R., Fine, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.002 · Cited by 91
Driver, J. A., Logroscino, G., Lu, L., Gaziano, J. M., & Kurth, T. (2011) · BMJ · doi:10.1136/bmj.d198 · Cited by 90
Tian, Y.-M., Chen, X., Luo, D.-Z., Zhang, X.-H., Xue, H., Zheng, L.-F., Yang, N., Wang, X.-M., & Zhu, J.-X. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.033 · Cited by 90
Zvara, Á., Szekeres, G., Janka, Z., Kelemen, J. Z., Cimmer, C., Sántha, M., & Puskás, L. G. (2005) · Disease Markers · doi:10.1155/2005/275318 · Cited by 90
Bistola, V., Arfaras-Melainis, A., Polyzogopoulou, E., Ikonomidis, I., & Parissis, J. (2019) · Cardiac failure review · doi:10.15420/cfr.2019.11.2 · Cited by 90
Close encounters of the monoamine kind: immune cells betray their nervous disposition
Meredith, E. J., Chamba, A., Holder, M. J., Barnes, N. M., & Gordon, J. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02166.x · Cited by 89
Bal, A., Bachelot, T., Savasta, M., Manier, M., Verna, J. M., Benabid, A. L., & Feuerstein, C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90227-5 · Cited by 89
Purves-Tyson, T. D., Owens, S. J., Rothmond, D. A., Halliday, G. M., Double, K. L., Stevens, J., McCrossin, T., & Weickert, C. S. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.257 · Cited by 89
Warren, B. L., Iñiguez, S. D., Alcantara, L. F., Wright, K. N., Parise, E. M., Weakley, S. K., & Bolaños‐Guzmán, C. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1470-11.2011 · Cited by 88
Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils
Cosentino, M., Marino, F., Bombelli, R., Ferrari, M., Lecchini, S., & Frigo, G. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00023-5 · Cited by 88
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment
Schifitto, G., Zhang, J., Evans, S. R., Sacktor, N. C., Simpson, D. M., Millar, L., Hung, V., Miller, E. N., Smith, E. V., Ellis, R. J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000268487.78753.0f · Cited by 88
Derivation of Urinary Dopamine from Plasma Dihydroxyphenylalanine in Humans
Wolfovitz, E., Grossman, E., Folio, C. J., Keiser, H. R., Kopin, I. J., & Goldstein, D. S. (1993) · Clinical Science · doi:10.1042/cs0840549 · Cited by 88
Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials
Xiang, Y.-Q., Zheng, W., Wang, S.-B., Yang, X.-H., Cai, D.-B., Ng, C. H., Ungvari, G. S., Kelly, D. L., Xu, W.-Y., & Xiang, Y.-T. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.11.012 · Cited by 88
Abreu, C. M., Veenhuis, R. T., Avalos, C. R., Graham, S., Parrilla, D. R., Ferreira, E. A., Queen, S. E., Shirk, E. N., Bullock, B. T., Li, M., et al. (2019) · mBio · doi:10.1128/mbio.01659-19 · Cited by 88
Amiri, S., Farhang, S., Ghoreishizadeh, M. A., Malek, A., & Mohammadzadeh, S. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1274 · Cited by 87
Cook‐Mills, J. M., Cohen, R. L., Perlman, R. L., & Chambers, D. A. (1995) · PubMed Central · Cited by 86
Rappaport, J., & Volsky, D. J. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0346-y · Cited by 86
Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages
Gaskill, P. J., Yano, H., Kalpana, G. V., Javitch, J. A., & Berman, J. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108232 · Cited by 86
Self-citationTakahashi, N., Nagai, Y., Ueno, S., Saeki, Y., & Yanagihara, T. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81452-r · Cited by 86
Rubin, L. H., Sacktor, N. C., Creighton, J. A., Du, Y., Endres, C. J., Pomper, M. G., & Coughlin, J. M. (2018) · AIDS · doi:10.1097/qad.0000000000001858 · Cited by 86
Seilicovich, A., Lasaga, M., Befumo, M. F., Duvilanski, B., Diaz, M. D. C., Rettori, V., & McCann, S. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11299 · Cited by 85
Cahill, E., Pascoli, V., Trifilieff, P., Savoldi, D., Kappès, V., Lüscher, C., Caboche, J., & Vanhoutte, P. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.73 · Cited by 85
Phillips, R. J., & Powley, T. L. (2012) · Autonomic Neuroscience · doi:10.1016/j.autneu.2012.02.004 · Cited by 85
Han, X., Li, B., Ye, X., Mulatibieke, T., Wu, J., Dai, J., Wu, D., Ni, J., Zhang, R., Xue, J., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14057 · Cited by 85
Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation
Montoya, A., Elgueta, D., Campos, J., Chovar, O., Falcón, P., Matus, S., Alfaro, I. E., Bono, M. R., & Pacheco, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1652-8 · Cited by 85
Dong, M.-X., Chen, G.-H., & Hu, L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.608520 · Cited by 85
The Discovery of Chemical Neurotransmitters
Valenstein, E. S. (2002) · Brain and Cognition · doi:10.1006/brcg.2001.1487 · Cited by 84
G Protein-Mediated Mitogen-Activated Protein Kinase Activation by Two Dopamine D2 Receptors
Choi, E.-Y., Jeong, D.-W., Park, K. W., & Baik, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0286 · Cited by 84
Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity
Contreras, F., Prado, C. E., González, H., Demane, D. F., Osorio‐Barrios, F., Osorio, F., Ugalde, V., López, E., Elgueta, D., Figueroa, A., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502420 · Cited by 84
Suominen, T., Uutela, P., Ketola, R. A., Bergquist, J., Hillered, L., Finel, M., Zhang, H., Laakso, A., & Kostiainen, R. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068007 · Cited by 83
Thobois, S., Vingerhoets, F. J. G., Fraix, V., Xie‐Brustolin, J., Mollion, H., Costes, N., Mertens, P., Benabid, A., Pollak, P., & Broussolle, E. (2004) · Archives of Neurology · doi:10.1001/archneur.61.11.1705 · Cited by 83
Activation of Microtubule‐Associated Protein Kinase (Erk) and p70 S6 Kinase by D2 Dopamine Receptors
Welsh, G. I., Hall, D. A., Warnes, A., Strange, P. G., & Proud, C. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052139.x · Cited by 83
Xue, R., Zhang, H., Pan, J., Du, Z., Zhou, W., Zhang, Z., Tian, Z., Zhou, R., & Bai, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02398 · Cited by 83
Bekhbat, M., Treadway, M. T., Goldsmith, D. R., Woolwine, B. J., Haroon, E., Miller, A. H., & Felger, J. C. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.015 · Cited by 83
Vascular dopamine receptors: Demonstration and characterization by studies
Brodde, O. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90406-4 · Cited by 82
The endogenous substrates of brain CYP2D
Wang, X., Li, J., Dong, G., & Yue, J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.12.025 · Cited by 82
Haskó, G., Szabó, C., Németh, Z. H., & Deitch, E. A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00459-3 · Cited by 82
Richtand, N. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301163 · Cited by 82
Tampa, M. Ş., Sârbu, M. I., Mitran, M.-I., Mitran, C. I., Matei, C., & Georgescu, S. R. (2018) · Disease Markers · doi:10.1155/2018/5823684 · Cited by 82
Targeting the immune system in the treatment of bipolar disorder
Rosenblat, J. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5175-x · Cited by 82
Bone-to-Brain: A Round Trip in the Adaptation to Mechanical Stimuli
Gerosa, L., & Lombardi, G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.623893 · Cited by 82
Henshall, D. C., & Engel, T. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00110 · Cited by 81
de la Mora, M. P., Gallegos-Cari, A., Crespo-Ramirez, M., Marcellino, D., Hansson, A. C., & Fuxe, K. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.045 · Cited by 81
Goldstein, D. S., Mezey, É., Yamamoto, T., Åneman, A., Friberg, P., & Eisenhofer, G. (1995) · Hypertension Research · doi:10.1291/hypres.18.supplementi_s93 · Cited by 81
Zanassi, P., Paolillo, M., Montecucco, A., Avvedimento, E. V., & Schinelli, S. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<544::aid-jnr7>3.0.co;2-9 · Cited by 81
Decreased Levels of Dopamine D3 Receptor mRNA in Schizophrenic and Bipolar Patients
Vogel, M., Pfeifer, S., Schaub, R., Grabe, H. J., Barnow, S., Freyberger, H. J., & Cascorbi, I. (2004) · Neuropsychobiology · doi:10.1159/000080958 · Cited by 81
Bliziotes, M. M., McLoughlin, S. W., Gunness, M. E., Fumagalli, F., Jones, S. R., & Caron, M. G. (2000) · Bone · doi:10.1016/s8756-3282(99)00232-x · Cited by 81
Li, A., Guo, H., Luo, X., Sheng, J., Yang, S., Yin, Y., Zhou, J., & Zhou, J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5510fje · Cited by 81
Vasopressor and Inotrope Therapy in Cardiac Critical Care
Jentzer, J. C., & Hollenberg, S. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620917630 · Cited by 81
Elevated plasma dopamine in posttraumatic stress disorder: A preliminary report
Hamner, M. B., & Diamond, B. I. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90302-t · Cited by 80
HIV, Tat and dopamine transmission
Gaskill, P. J., Miller, D. R., Gamble‐George, J., Yano, H., & Khoshbouei, H. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.015 · Cited by 80
Self-citationBergamini, G., Mechtersheimer, J., Azzinnari, D., Sigrist, H., Buerge, M., Dallmann, R., Freije, R., Kouraki, A., Opacka‐Juffry, J., Seifritz, E., et al. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.01.004 · Cited by 80
Jha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T. L., Mayes, T. L., & Trivedi, M. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.005 · Cited by 79
Renal Dopamine Receptors, Oxidative Stress, and Hypertension
Cuevas, S., Villar, V. A. M., José, P. A., & Armando, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917553 · Cited by 79
Salomone, S., & Waeber, C. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00009 · Cited by 79
Gaskill, P. J., Calderon, T. M., Coley, J. S., & Berman, J. W. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9443-y · Cited by 79
Self-citationSarkar, C., Das, S., Chakroborty, D., Chowdhury, U. R., Basu, B., Dasgupta, P., & Basu, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7525 · Cited by 79
Czub, S., Koutsilieri, E., Sopper, S., Czub, M., Stahl‐Hennig, C., Jg, M., Pedersen, V., Gsell, W., Heeney, J. L., Gerlach, M., et al. (2001) · PubMed · doi:10.1007/s004010000313 · Cited by 79
Camara, A., Sow, M., Touré, A. F., Sako, F. B., Camara, I., Soumaoro, K., Délamou, A., & Doukouré, M. (2020) · Epidemiology and Infection · doi:10.1017/s095026881900222x · Cited by 79
Aguilar‐Valles, A., Rodrigue, B., & Matta‐Camacho, E. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00852 · Cited by 79
Yan, Y., Pan, J., Chen, Y., Xing, W., Li, Q., Wang, D., Zhou, X., Xie, J., Miao, C., Yuan, Y., et al. (2020) · 癌症:英文版 · doi:10.1002/cac2.12103 · Cited by 79
Dopamine regulation of [3H]acetylcholine release from guinea-pig stomach.
Kusunoki, M., Taniyama, K., & Tanaka, C. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23692-8 · Cited by 78
Wang, C., Buck, D. C., Yang, R., Macey, T. A., & Neve, K. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03055.x · Cited by 78
Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines
Nair, V. D., Olanow, C. W., & Sealfon, S. C. (2003) · Biochemical Journal · doi:10.1042/bj20030017 · Cited by 78
Aripiprazole acts as a selective dopamine D2receptor partial agonist
Wood, M. D., & Reavill, C. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.6.771 · Cited by 78
Aggeletopoulou, I., Assimakopoulos, S. F., Konstantakis, C., & Triantos, C. K. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i36.4093 · Cited by 78
Beydoun, M. A., Obhi, H. K., Weiss, J., Canas, J. A., Beydoun, H. A., Evans, M. K., & Zonderman, A. B. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0408-2 · Cited by 78
Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders
Irollo, E., Luchetta, J., Ho, C.-T., Nash, B., & Meucci, O. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03785-y · Cited by 78
Schwartz, C., Eberle, J. U., & Voehringer, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.049 · Cited by 77
D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells
Yu, P., Yang, Z., Jones, J. E., Wang, Z., Owens, S. A., Mueller, S. C., Felder, R. A., & José, P. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66007.x · Cited by 77
O’Brien, R. L. F., & Uíttenbogaart, C. H. (2010) · Immunologic Research · doi:10.1007/s12026-010-8170-1 · Cited by 77
Zhan, L., Kerr, J. R., Lafuente, M. J., Maclean, A. W., Chibalina, M. V., Liu, B., Burke, B., Bevan, S., & Nasir, J. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01128.x · Cited by 77
HIV Infection of Macrophages: Implications for Pathogenesis and Cure
Clayton, K., Garcia, V., Clements, J. E., & Walker, B. D. (2017) · Pathogens and Immunity · doi:10.20411/pai.v2i2.204 · Cited by 77
Mackie, P. M., Lebowitz, J., Saadatpour, L., Nickoloff, E., Gaskill, P. J., & Khoshbouei, H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.020 · Cited by 77
Self-citationDopamine promotes cellular iron accumulation and oxidative stress responses in macrophages
Dichtl, S., Haschka, D., Nairz, M., Seifert, M., Volani, C., Lutz, O., & Weiss, G. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.001 · Cited by 76
Namba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76
Proarrhythmic Effects of Intravenous Vasopressors
Tisdale, J. E., Patel, R. V., Webb, C. R., Borzak, S. L., & Zarowitz, B. J. M. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900309 · Cited by 76
Platania, C. B. M., Salomone, S., Leggio, G. M., Drago, F., & Bucolo, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044316 · Cited by 76
Qin, T., Wang, C., Chen, X., Duan, C., Zhang, X., Zhang, J., Chai, H., Tang, T., Chen, H., Yue, J., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.021 · Cited by 76
Modulation of Blood Pressure and Obesity With the Dopamine D2 Receptor GeneTaqI Polymorphism
Thomas, G. N., Tomlinson, B., & Critchley, J. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.177 · Cited by 76
Transient and chronic seizure‐induced inflammation in human focal epilepsy
Butler, T., Li, Y., Tsui, W., Friedman, D. J., Maoz, A., Wang, X., Harvey, P., Tanzi, E. B., Morim, S., Kang, Y., et al. (2016) · Epilepsia · doi:10.1111/epi.13457 · Cited by 76
Nakagome, K., Imamura, M., Okada, H., Kawahata, K., Inoue, T., Hashimoto, K., Harada, H., Higashi, T., Takagi, R., Nakano, K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001274 · Cited by 75
Cognitive Performance and Regional Brain Volume in Human Immunodeficiency Virus Type 1 Infection
Kieburtz, K. D., Ketonen, L., Cox, C., Grossman, H. T., Holloway, R. G., Booth, H., Hickey, C., Feigin, A., & Caine, E. D. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020059016 · Cited by 75
Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model
Vollmar, P., Haghikia, A., Dermietzel, R., & Faustmann, P. M. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007729 · Cited by 75
Fujimura, R. K., Goodkin, K., Petito, C. K., Douyon, R., Feaster, D. J., Concha, M., & Shapshak, P. (1997) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199711010-00002 · Cited by 75
High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder
Lu, Y.-R., Rao, Y., Mou, Y.-J., Chen, Y., Lou, H., Zhang, Y., Zhang, D.-X., Xie, H., Hu, L., & Fang, P. (2019) · Medicine · doi:10.1097/md.0000000000014419 · Cited by 75
Stahl, S. M. (2007) · CNS Spectrums · doi:10.1017/s1092852900015418 · Cited by 74
Coley, J. S., Calderon, T. M., Gaskill, P. J., Eugenin, E. A., & Berman, J. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117450 · Cited by 74
Self-citationHigher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder
Benedetti, F., Poletti, S., Hoogenboezem, T. A., Locatelli, C., de Wit, H., Wijkhuijs, A. J. M., Colombo, C., & Drexhage, H. A. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11310 · Cited by 74
Inhibition of Nigrostriatal Dopamine Release by Striatal GABAAand GABABReceptors
Lopes, E. F., Roberts, B. M., Siddorn, R. E., Clements, M. A., & Cragg, S. J. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2028-18.2018 · Cited by 74
Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women
Mehta, N. D., Stevens, J. S., Li, Z., Gillespie, C. F., Fani, N., Michopoulos, V., & Felger, J. C. (2020) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsz100 · Cited by 74
Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy
Rocha, L., Alonso‐Vanegas, M., Villeda‐Hernández, J., Mújica, M., Cisneros-Franco, J. M., Lopez-Gómez, M., Zavala‐Tecuapetla, C., Frías‐Soria, C. L., Segovia‐Vila, J., & Borsodi, A. D. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.006 · Cited by 73
Mereu, M., Contarini, G., Buonaguro, E. F., Latte, G., Managò, F., Iasevoli, F., de Bartolomeis, A., & Papaleo, F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.037 · Cited by 73
Neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein
Dickstein, L. P., Liow, J., Austermuehle, A., Zoghbi, S. S., Inati, S. K., Zaghloul, K. A., Zanotti‐Fregonara, P., & Theodore, W. H. (2019) · Epilepsia · doi:10.1111/epi.15967 · Cited by 73
Eosinophils: Cells known for over 140 years with broad and new functions
Aoki, A., Hirahara, K., Kiuchi, M., & Nakayama, T. (2020) · Allergology International · doi:10.1016/j.alit.2020.09.002 · Cited by 73
León‐Rivera, R., Veenstra, M., Donoso, M., Tell, E., Eugenín, E. A., Morgello, S., & Berman, J. W. (2021) · mBio · doi:10.1128/mbio.03633-20 · Cited by 73
Putting on the Brakes: Cyclic AMP as a Multipronged Controller of Macrophage Function
Peters-Golden, M. L. (2009) · Science Signaling · doi:10.1126/scisignal.275pe37 · Cited by 72
Nuclear Factor‐κB is Involved in the Catecholaminergic Suppression of Immunocompetent Cells
Bergquist, J., Ohlsson, B. G., & Tarkowski, A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05394.x · Cited by 72
Banday, A. A., Fazili, F. R., & Lokhandwala, M. F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121373 · Cited by 72
Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine
Yang, F., Chen, Z., Pathak, J. L., Carneiro, A. M. D., & Chung, C. Y. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00309 · Cited by 72
Topical Review: Infantile Spasms: Therapy and Outcome
Riikonen, R. (2004) · Journal of Child Neurology · doi:10.1177/088307380401900601 · Cited by 71
Cotter, R., Pei, Y., Mus, L., Harmeier, A., Gainetdinov, R. R., Hoener, M. C., & Canales, J. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00039 · Cited by 71
Cited by
Uncovering the metabolic impact of acute psychological stress in young adults
Frempong, G. A., Goni, G., Lorenzo-Tejedor, M., De la Cámara, C., Lázaro, J., Mangialavori Rasia, E., Aguiló, J., Bailon, R., & Bernal, M. L. (2026) · Scientific Reports · doi:10.1038/s41598-025-29572-4 · Cited by 3
Metadata
- Authors
- Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 75
- Issue
- 1
- Pages
- 62-158
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W4311937162
- Cited by
- 308
- References
- 1,227
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.